Naveen Vasudev

17.7k total citations · 1 hit paper
70 papers, 1.8k citations indexed

About

Naveen Vasudev is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Naveen Vasudev has authored 70 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 24 papers in Molecular Biology and 21 papers in Oncology. Recurrent topics in Naveen Vasudev's work include Renal cell carcinoma treatment (38 papers), Renal and related cancers (11 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Naveen Vasudev is often cited by papers focused on Renal cell carcinoma treatment (38 papers), Renal and related cancers (11 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Naveen Vasudev collaborates with scholars based in United Kingdom, Germany and Japan. Naveen Vasudev's co-authors include Andrew R. Reynolds, Rosamonde E. Banks, Peter J. Selby, David J. Beech, Hannah J. Gaunt, Jon Cartledge, Douglas Thompson, Jonathan Welti, Melanie J. Ludlow and Katsuhiko Muraki and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Naveen Vasudev

65 papers receiving 1.8k citations

Hit Papers

Anti-angiogenic therapy for cancer: current progress, unr... 2014 2026 2018 2022 2014 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
    2014 562 citations Naveen Vasudev, Andrew R. Reynolds profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naveen Vasudev United Kingdom 22 903 490 384 380 251 70 1.8k
Han Si United States 21 1.4k 1.6× 424 0.9× 464 1.2× 449 1.2× 224 0.9× 55 2.7k
Ying Shen China 30 1.0k 1.1× 336 0.7× 355 0.9× 295 0.8× 353 1.4× 129 2.4k
John J. Grygiel Australia 25 893 1.0× 958 2.0× 350 0.9× 494 1.3× 235 0.9× 49 2.4k
Marie Brevet France 27 833 0.9× 1.3k 2.7× 386 1.0× 816 2.1× 278 1.1× 76 2.8k
Jingdong Li China 23 1.3k 1.4× 310 0.6× 430 1.1× 325 0.9× 494 2.0× 124 2.5k
Daniele Avanzato Italy 15 996 1.1× 236 0.5× 338 0.9× 465 1.2× 92 0.4× 18 1.8k
Dong Chen China 26 861 1.0× 300 0.6× 251 0.7× 328 0.9× 478 1.9× 84 1.8k
Weigang Fang China 28 1.1k 1.2× 249 0.5× 484 1.3× 433 1.1× 173 0.7× 80 2.1k

Countries citing papers authored by Naveen Vasudev

Since Specialization
Citations

This map shows the geographic impact of Naveen Vasudev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naveen Vasudev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naveen Vasudev more than expected).

Fields of papers citing papers by Naveen Vasudev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naveen Vasudev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naveen Vasudev. The network helps show where Naveen Vasudev may publish in the future.

Co-authorship network of co-authors of Naveen Vasudev

This figure shows the co-authorship network connecting the top 25 collaborators of Naveen Vasudev. A scholar is included among the top collaborators of Naveen Vasudev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naveen Vasudev. Naveen Vasudev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCarthy, Elizabeth, Amy L. Chadwick, J.J. Soto Castillo, et al.. (2025). A multi-centre review of the use of adjuvant pembrolizumab for renal cell carcinoma.. Journal of Clinical Oncology. 43(5_suppl). 484–484.
2.
Lee, Joshua, Elizabeth A. Snell, Julia Brown, et al.. (2024). Long-read RNA sequencing of archival tissues reveals novel genes and transcripts associated with clear cell renal cell carcinoma recurrence and immune evasion. Genome Research. 34(11). 1849–1864. 1 indexed citations
3.
4.
Hussain, Syed A., J.F. Lester, Richard A. Jackson, et al.. (2022). Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial. White Rose Research Online (University of Leeds, The University of Sheffield, University of York). 20 indexed citations
5.
6.
Vasudev, Naveen, Rocío López‐Vacas, Michelle Wilson, et al.. (2022). 1473P A prognostic microRNA-based signature for relapse risk prediction and definition of therapeutic targets in patients with high-risk localized clear cell renal cell carcinoma. Annals of Oncology. 33. S1220–S1220. 1 indexed citations
7.
Wah, Tze Min, Jonathan Smith, Paul Bassett, et al.. (2021). Irreversible electroporation (IRE) in renal cell carcinoma (RCC): a mid-term clinical experience. European Radiology. 31(10). 7491–7499. 24 indexed citations
8.
Vasudev, Naveen, Sarah Brown, Tom Waddell, et al.. (2021). LBA29 Nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced renal cell carcinoma: A randomized phase II trial (PRISM). Annals of Oncology. 32. S1304–S1305. 4 indexed citations
9.
Aversa, Caterina, Arighno Das, Deborah Enting, et al.. (2020). 765P Predicting survival in urothelial cancer patients after immunotherapy using real-world data. Annals of Oncology. 31. S590–S590. 3 indexed citations
10.
Robinson, Simon P., Jessica K.R. Boult, Naveen Vasudev, & Andrew R. Reynolds. (2017). Monitoring the Vascular Response and Resistance to Sunitinib in Renal Cell Carcinoma In Vivo with Susceptibility Contrast MRI. Cancer Research. 77(15). 4127–4134. 20 indexed citations
11.
Gaunt, Hannah J., Naveen Vasudev, & David J. Beech. (2016). Transient receptor potential canonical 4 and 5 proteins as targets in cancer therapeutics. European Biophysics Journal. 45(7). 611–620. 35 indexed citations
12.
Vasudev, Naveen, et al.. (2016). Letters of condolence: assessing attitudes and variability in practice. ecancermedicalscience. 10. 642–642. 3 indexed citations
13.
Ludlow, Melanie J., Hannah J. Gaunt, Hussein N. Rubaiy, et al.. (2016). (−)-Englerin A-evoked Cytotoxicity Is Mediated by Na+ Influx and Counteracted by Na+/K+-ATPase. Journal of Biological Chemistry. 292(2). 723–731. 40 indexed citations
14.
Bridgeman, Victoria L., Elaine Y. Wan, Shane Foo, et al.. (2015). Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma. Molecular Cancer Therapeutics. 15(1). 172–183. 38 indexed citations
15.
Ralph, Christy, Satinder Jagdev, Patricia Harnden, et al.. (2014). Metastatic castrate-resistant prostate cancer with a late, complete and durable response to docetaxel chemotherapy: a case report. Journal of Medical Case Reports. 8(1). 122–122. 2 indexed citations
16.
Vasudev, Naveen, Vicky Goh, Jaspal Juttla, et al.. (2013). Changes in tumour vessel density upon treatment with anti-angiogenic agents: relationship with response and resistance to therapy. British Journal of Cancer. 109(5). 1230–1242. 36 indexed citations
17.
Vasudev, Naveen, et al.. (2010). Febrile neutropenia. BMJ. 341(dec17 1). c6981–c6981. 5 indexed citations
18.
Vasudev, Naveen, David A. Cairns, Geoff Hall, et al.. (2010). The prognostic and predictive value of CA-125 regression during neoadjuvant chemotherapy for advanced ovarian or primary peritoneal carcinoma. Archives of Gynecology and Obstetrics. 284(1). 221–227. 27 indexed citations
19.
Vasudev, Naveen, David A. Cairns, Roisean E. Ferguson, et al.. (2009). Pre-operative urinary cathepsin D is associated with survival in patients with renal cell carcinoma. British Journal of Cancer. 101(7). 1175–1182. 24 indexed citations
20.
Vasudev, Naveen, Janet E. Brown, Sarah Brown, et al.. (2008). Prognostic Factors in Renal Cell Carcinoma: Association of Preoperative Sodium Concentration with Survival. Clinical Cancer Research. 14(6). 1775–1781. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Han Si Breakdown of academic impact, for papers by Ying Shen Breakdown of academic impact, for papers by John J. Grygiel Breakdown of academic impact, for papers by Marie Brevet Breakdown of academic impact, for papers by Jingdong Li Breakdown of academic impact, for papers by Daniele Avanzato Breakdown of academic impact, for papers by Dong Chen Breakdown of academic impact, for papers by Weigang Fang
Rankless by CCL
2026